Clinicopathological features of sarcoidosis manifesting as generalized chronic myopathy

Journal of Neurology

Volumn 262, Issue 4, 2015, Pages 1035-1045

  Maeshima, Shinya ^a   Koike, Haruki ^a   Noda, Seiya ^a   Noda, Tomoko ^a   Nakanishi, Hirotaka ^a   Iijima, Masahiro ^a   Ito, Mizuki ^a   Kimura, Seigo ^a   Sobue, Gen ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Muscle biopsy; Myopathy; Prognosis; Sarcoidosis

Indexed keywords

CREATINE KINASE; LEUKOCYTE ANTIGEN;

AGED; BIOPSY; BLOOD; CHRONIC DISEASE; COMPUTER ASSISTED TOMOGRAPHY; ELECTROMYOGRAPHY; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; METABOLISM; MIDDLE AGED; MUSCLE DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; RADIOGRAPHY; RETROSPECTIVE STUDY; SARCOIDOSIS; SKELETAL MUSCLE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIGENS, CD; BIOPSY; CHRONIC DISEASE; CREATINE KINASE; ELECTROMYOGRAPHY; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MUSCULAR DISEASES; RETROSPECTIVE STUDIES; SARCOIDOSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84939955595     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-015-7680-0     Document Type: Article

References (47)

1. Silverstein A, Siltzbach LE (1969) Muscle involvement in sarcoidosis. Asymptomatic, myositis, and myopathy. Arch Neurol 21:235–241
2. Douglas AC, Macleod JG, Matthews JD (1973) Symptomatic sarcodosis of skeletal muscle. J Neurol Neurosurg Psychiatry 36:1034–1040
3. Jamal MM, Cilursu AM, Hoffman EL (1988) Sarcoidosis presenting as acute myositis. Report and review of the literature. J Rheumatol 15:1868–1871
4. Le Roux K, Streichenberger N, Vial C, Petiot P, Feasson L, Bouhour F et al (2007) Granulomatous myositis: a clinical study of thirteen cases. Muscle Nerve 35:171–177
5. Otake S (1994) Sarcoidosis involving skeletal muscle: imaging findings and relative value of imaging procedures. Am J Roentgenol 162:369–375
6. Hinterbuchner CN, Hinterbuchner LP (1964) Myopathic syndrome in muscular sarcoidosis. Brain 87:355–366
7. Ammitzboll F (1956) A case of Boeck’s sarcoid with isolated localizationi in the musculature. Acta Rheumatol Scand 2:3–10
8. McConkey B (1958) Muscular dystrophy in sarcoidosis. Arch Intern Med 102:443–446
9. Harvey JC (1959) A myopathy of Boeck’s sarcoid. Am J Med 26:356–363
10. Kryger J, Rønnov-Jessen V (1959) Myopathy in Boeck’s sarcoid. Acta Rheumatol Scand 5:314–322
11. Brun A (1961) Chronic polymyositis on the basis of sarcoidosis. Acta Psychiatr Neurol Scand 36:515–523
12. Crompton MR, MacDermot V (1961) Sarcoidosis associated with progressive muscular wasting and weakness. Brain 84:62–74
13. Talbot PS (1967) Sarcoid myopathy. Br Med J 4:465–466
14. Prayson RA (1999) Granulomatous myositis. Clinicopathologic study of 12 cases. Am J Clin Pathol 112:63–68
15. Gardner-Thorpe C (1972) Muscle weakness due to sarcoid myopathy. Six case reports and an evaluation of steroid therapy. Neurology 22:917–928
16. Wolfe SM, Pinals RS, Aelion JA, Goodman RE (1987) Myopathy in sarcoidosis: clinical and pathologic study of four cases and review of the literature. Semin Arthritis Rheum 16:300–306
17. Zisman DA, Shorr AF, Lynch JP (2002) Sarcoidosis involving the musculoskeletal system. Semin Respir Crit Care Med 23:555–570
18. Hewlett RH, Brownell B (1975) Granulomatous myopathy: its relationship to sarcoidosis and polymyositis. J Neurol Neurosurg Psychiatry 38:1090–1099
19. Judson MA, Hirst K, Iyengar SK, Rybicki BA, El-Ghormli L, Baughman RP et al (2006) Comparison of sarcoidosis phenotypes among affected African-American siblings. Chest 130:855–862
20. Swash M, Brown MM, Thakkar C (1995) CT muscle imaging and the clinical assessment of neuromuscular disease. Muscle Nerve 18:708–714
21. Ohyama K, Koike H, Katsuno M, Takahashi M, Hashimoto R, Kawagashira Y et al (2014) Muscle atrophy in chronic inflammatory demyelinating polyneuropathy: a computed tomography assessment. Eur J Neurol 21:1002–1010
22. Adams EM, Chow CK, Premkumar A, Plotz PH (1995) The idiopathic inflammatory myopathies: spectrum of MR imaging findings. Radiographics 15:563–574
23. Moore SL, Teirstein A, Golimbu C (2005) MRI of sarcoidosis patients with musculoskeletal symptoms. Am J Roentgenol 185:154–159
24. Garcia J (2000) MRI in inflammatory myopathies. Skeletal Radiol 29:425–438
25. Lampa J, Nennesmo I, Einarsdottir H, Lungberg I (2001) MRI guided muscle biopsy confirmed polymyositis diagnosis in a patient with interstitial lung disease. Ann Rheum Dis 60:423–426
26. Inukai A, Kuru S, Liang Y, Takano A, Kobayashi Y, Doyu M et al (2000) Expression of HLA-DR and its enhancing molecules in muscle fibers in polymyositis. Muscle Nerve 23:385–392
27. Kuru S, Inukai A, Kato T, Liang Y, Kimura S, Sobue G (2003) Expression of tumor necrosis factor-alpha in regenerating muscle fibers in inflammatory and non-inflammatory myopathies. Acta Neuropathol 105:217–224
28. Liang Y, Inukai A, Kuru S, Kato T, Doyu M, Sobue G (2000) The role of lymphotoxin in pathogenesis of polymyositis. Acta Neuropathol 100:521–527
29. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19:604–607
30. Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H Jr, Bresnitz EA et al (2001) Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 164:1885–1889
31. Fonseca GA, Baca S, Altman RD (1993) Acute myositis and dermatitis as the initial presentation of sarcoidosis. Clin Exp Rheumatol 11:553–556
32. Ost D, Yeldandi A, Cugell D (1995) Acute sarcoid myositis with respiratory muscle involvement. Case report and review of the literature. Chest 107:879–882
33. Needham M, James I, Corbett A, Day T, Christiansen F, Phillips B et al (2008) Sporadic inclusion body myositis: phenotypic variability and influence of HLA-DR3 in a cohort of 57 Australian cases. J Neurol Neurosurg Psychiatry 79:1056–1060
34. Nakanishi H, Koike H, Matsuo K, Tanaka F, Noda T, Fujikake A et al (2013) Demographic features of Japanese patients with sporadic inclusion body myositis: a single-center referral experience. Intern Med 52:333–337
35. Needham M, Mastaglia F (2007) Inclusion body myositis:current pathogenetic concepts and diagnostic and therapeutic approaches. Lancet Neurol 6:620–631
36. Dimachkie MM, Barohn RJ (2012) Inclusion body myositis. Semin Neurol 32:237–245
37. Dalakas MC, Hohlfeld R (2003) Polymyositis and dermatomyositis. Lancet 362:971–982
38. Dalakas MC (1991) Polymyositis, dermatomyositis, and inclusion-body myositis. N Engl J Med 325:1487–1498
39. Callen JP (2000) Dermatomyositis. Lancet 355:53–57
40. Liem IH, Drent M, Antevska E, Lamers RJ, Heidendal GA (1998) Intense muscle uptake of gallium-67 in a patient with sarcoidosis. J Nucl Med 39:1605–1607
41. Weber M-A, Jappe U, Essig M, Krix M, Ittrich C, Hagen Huttner B et al (2006) Contrast-enhanced ultrasound in dermatomyositis- and polymyositis. J Neurol 253:1625–1632
42. Kumamoto T, Yukishige K, Ito T, Nagao S, Mori T, Ueyama H et al (2002) Cellular distribution of proteolytic enzymes in the skeletal muscle of sarcoid myopathy. Acta Neuropathol 104:38–44
43. Ibi T, Sahashi K, Ling J, Mitsuma T (1995) Expression of MHC and cell adhesion molecules in muscular sarcoidosis. Rinsho Shinkeigaku 35:996–1002
44. Kim DS, Paik SH, Lim CM, Lee SD, Koh Y, Kim WS et al (1999) Value of ICAM-1 expression and soluble ICAM-1 level as a marker of activity in sarcoidosis. Chest 115:1059–1065
45. Striz I, Wang YM, Kalaycioglu O, Costabel U (1992) Expression of alveolar macrophage adhesion molecules in pulmonary sarcoidosis. Chest 102:882–886
46. Koike H, Misu K, Yasui K, Kameyama T, Ando T, Yanagi T et al (2000) Differential response to corticosteroid therapy of MRI findings and clinical manifestations in spinal cord sarcoidosis. J Neurol 247:544–549
47. Yasui K, Ishigaki S, Koike H, Ieda T, Yoshida M, Hashizume Y et al (2000) Correlation of magnetic resonance imaging findings and histopathology of lesion distribution of spinal cord sarcoidosis at post-mortem. Neuropathol Appl Neurobiol 26:481–487